Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders
This article will explain how GLP-1 drugs work, discuss their potential link to migraine, and provide tips on what to do if you experience headaches while taking these treatments
Dial your prescribed dose (typically starting at 0.25 mg for the first 4 weeks)
The connection between weight loss methods and hair outcomes GLP-1 medications are not the only weight loss approach that can trigger hair shedding
5 Scientists are currently researching the possibility of using next-generation GLP-1 drugs to treat disorders of the central nervous system, such as Alzheimers disease, Parkinsons disease, and stroke, neuropsychiatric conditions, and cardiovascular disease
A recurring theme across non-incretin metabolic peptides is that early development efforts were constrained by pleiotropy, cardiovascular effects, or incomplete receptor characterization rather than by lack of metabolic relevance
